Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 9,034 | 6,855 | 4,939 | 3,423 | 3,020 |
| Operating Income | -9,034 | -6,855 | -4,939 | -3,423 | -3,020 |
| Other Income | 138 | 102 | 62 | 23 | -15 |
| Pre-tax Income | -8,896 | -6,753 | -4,877 | -3,400 | -3,035 |
| Net Income Continuous | -8,896 | -6,753 | -4,877 | -3,400 | -3,035 |
| Net Income | $-8,896 | $-6,753 | $-4,877 | $-3,400 | $-3,035 |
| EPS Basic Total Ops | -10.50 | -8.00 | -6.00 | -4.50 | -5.25 |
| EPS Basic Continuous Ops | -10.57 | -8.04 | -5.98 | -4.49 | -5.14 |
| EPS Diluted Total Ops | -10.50 | -8.00 | -6.00 | -4.50 | -5.25 |
| EPS Diluted Continuous Ops | -10.57 | -8.04 | -5.98 | -4.49 | -5.14 |
| EBITDA(a) | $-9,034 | $-6,855 | $-4,939 | $-3,423 | $-3,020 |